Cargando…
Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
BACKGROUND: Current guidelines suggest reduction of DMARDs can be considered in RA patients in remission. Objectives were (1) to estimate the relative importance of patient characteristics rheumatologists consider in their decision to de-escalate (2) to assess whether heterogeneity exists among rheu...
Autores principales: | Kuijper, T. Martijn, Folmer, Riëtte, Stolk, Elly A., Hazes, Johanna M. W., Luime, Jolanda J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405491/ https://www.ncbi.nlm.nih.gov/pubmed/28446212 http://dx.doi.org/10.1186/s13075-017-1287-z |
Ejemplares similares
-
Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients
por: Nathalie, Luurssen-Masurel, et al.
Publicado: (2021) -
Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients
por: Luurssen-Masurel, Nathalie, et al.
Publicado: (2022) -
Focus group interviews reveal reasons for differences in the perception of disease activity in rheumatoid arthritis
por: Walter, Margot J. M., et al.
Publicado: (2016) -
Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study
por: Walter, Margot J. M., et al.
Publicado: (2018) -
A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis
por: Buisman, Leander R., et al.
Publicado: (2016)